PCN131 COST EFFECTIVENESS OF PEMETREXED IN COMBINATION WITH PEMBROLIZUMAB AND PLATINUM CHEMOTHERAPY (PEM+PEMBRO+PLAT), FOR INITIAL TREATMENT OF PATIENTS WITH METASTATIC NON-SQUAMOUS (NSQ) NON-SMALL CELL LUNG CANCER (NSCLC) IN THE U.S.
Aggarwal, H., Muehlenbein, C.E., Klein, T., Winfree, K.B., Bly, C.A., Zhu, Y., Perk, S., Smolen, L.J.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.255
Date:
May, 2019
File:
PDF, 382 KB
english, 2019
File converter
More search results
More benefits 
